Canadian patented drug prices : gauging the change in reference countries.: YN5-258/2022E-PDF
"The Parliamentary Budget Officer (PBO) supports Parliament by providing economic and financial analysis for the purposes of raising the quality of parliamentary debate and promoting greater budget transparency and accountability. Regulatory changes for how the Patented Medicines Prices Review Board (PMPRB) formulates price ceilings for patented drugs have been proposed and are due to come into effect in July of 2022. This report examines the proposed change and quantifies its long-term impact. We find that a change to the median of eleven comparator countries is important, but that more flexibility to re-adjust prices would potentially contribute more to reducing expenditures by Canadians."
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.917914&sl=0
| Department/Agency | Canada. Office of the Parliamentary Budget Officer, issuing body. |
|---|---|
| Title | Canadian patented drug prices : gauging the change in reference countries. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Prix canadiens des médicaments brevetés : mesurer l'importance de la modification dans les pays de référence. "RP-2223-008-S_e." Includes bibliographical references. |
| Publishing information | [Ottawa] : Office of the Parliamentary Budget Officer = Bureau du Directeur parlementaire du budget, June 14, 2022. ©2022 |
| Description | 1 online resource (20 pages) : colour illustrations |
| Catalogue number |
|
| Subject terms | Patent medicines -- Prices -- Canada. Patent medicines -- Prices -- Law and legislation -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: